Loxapine is a medicine used to treat certain mental health conditions like schizophrenia. It helps manage symptoms like hallucinations and delusions. It's taken as a pill, usually once a day.
Every report comes from a Lived member, sent anonymously.
Have you tried Loxapine for Schizophrenia?
Loxapine is a prescription antipsychotic medicine. Taken by mouth as capsules, it is approved to treat schizophrenia, a long-term mental illness that affects how a person thinks, feels and perceives reality. It can reduce symptoms such as hallucinations (hearing or seeing things others do not) and delusions (firmly held false beliefs). Its safety and effectiveness have not been established in children. A second product, Adasuve, delivers a single dose of loxapine through a one-time-use inhaler. It has a different purpose: calming acute agitation in adults with schizophrenia or bipolar I disorder. Healthcare staff give it in a specially certified healthcare setting; it is never prescribed for use at home. The original capsule brand, Loxitane, is no longer sold in the US, and the capsules are now available as generic loxapine. Loxapine is an older medicine. A Cochrane review of 41 trials found that, over the short term, it controlled schizophrenia symptoms about as well as other antipsychotics, both older ones and newer ones such as risperidone and quetiapine, with a side effect pattern resembling the older generation of antipsychotics.
Loxapine blocks receptors for dopamine and serotonin, two chemical messengers that brain cells use to signal one another. Receptors are the docking sites where these messengers attach and pass on their signal. By damping that signaling, loxapine decreases the abnormal excitement in the brain that drives psychotic symptoms and agitation, although exactly how it produces its benefit has not been established. It also has a calming, sedating effect. In healthy volunteers, sedation began 20 to 30 minutes after an oral dose, peaked within a few hours and lasted about 12 hours. The inhaled form acts faster: in trials, its effect on agitation was apparent within 10 minutes.
Loxapine capsules come in 5, 10, 25 and 50 mg strengths and are usually taken in divided doses two to four times a day. Treatment typically starts low and is raised fairly quickly over the first seven to ten days until symptoms are under control. The label gives 60 to 100 mg a day as the usual range and advises against more than 250 mg a day. For longer-term treatment, the prescriber aims for the lowest dose that keeps symptoms controlled, which for many people is 20 to 60 mg a day. Dose changes should be planned with the prescriber. Adasuve is handled entirely by healthcare staff. They give a single 10 mg inhalation, no more than one dose in 24 hours, after asking about lung disease and listening to the chest. Because the inhaled form can cause bronchospasm (a sudden tightening of the airways that can become life-threatening), it is not used in people with asthma, COPD (chronic obstructive pulmonary disease) or another lung disease that causes airway spasm, in anyone wheezing or currently using medicines for those conditions, or in anyone who had bronchospasm after a previous dose. Staff watch the person for at least an hour afterward, and wheezing, shortness of breath, chest tightness or cough should be reported to them.
Drowsiness, usually mild, is common at the start of treatment or after a dose increase and tends to fade with continued use. Dry mouth, a stuffy nose, constipation and blurred vision can occur, as can dizziness, a faster heartbeat or lightheadedness on standing up. Combined with sleepiness, that lightheadedness can lead to falls and injuries, which matters most for older adults. Nausea and weight changes are reported in some people. With the inhaled form, the most common effects are an unpleasant taste, sleepiness and throat irritation. Movement-related side effects are frequent with loxapine, often in the first days of treatment. They can resemble Parkinson's disease (tremor, stiff muscles, drooling, a less expressive face) or take the form of akathisia, an uncomfortable inner restlessness that makes it hard to sit still. They are usually not severe, and lowering the dose or adding a medicine that counters them typically helps, so they are worth reporting rather than enduring. Like other antipsychotics, loxapine raises prolactin, a hormone that can cause breast milk discharge, missed periods, breast enlargement or erection problems. With longer use, some people develop tardive dyskinesia: involuntary, repetitive movements, most often of the tongue, lips, face or jaw, such as chewing motions, lip puckering or tongue thrusting. It can become permanent. The risk grows with the length of treatment and the total amount taken, and it is highest in older adults, especially women. New movements like these should be raised with the prescriber soon, because stopping or changing treatment early may keep them from progressing. Two uncommon reactions are emergencies. A sudden muscle spasm that tightens the throat or makes swallowing or breathing difficult, most likely in the first days of treatment, needs emergency care right away. High fever with stiff muscles, confusion, heavy sweating or a racing or irregular heartbeat can signal neuroleptic malignant syndrome, a rare but potentially fatal reaction to antipsychotics, and also needs emergency care.
Like all antipsychotics, loxapine carries a boxed warning, the most prominent warning the US Food and Drug Administration requires on a label: older adults with dementia who are treated with antipsychotics for psychosis have a higher risk of death, mostly from heart problems or infections such as pneumonia. Loxapine is not approved for dementia-related psychosis. The inhaled form carries a second boxed warning, for the airway spasm described under Dosage & Administration. Loxapine adds to the effects of alcohol and other sedating drugs, such as opioid pain medicines, barbiturates and benzodiazepines (anti-anxiety and sedative medicines). Rare cases of dangerously slowed breathing, stupor and low blood pressure have occurred when it was combined with lorazepam, a benzodiazepine. It should not be used by someone who is in a coma or heavily sedated from alcohol or drugs, or by people allergic to loxapine or to amoxapine, a closely related medicine. Driving and operating machinery should wait until a person knows how loxapine affects them, especially in the first days. Several health conditions call for extra care. Loxapine lowers the seizure threshold, so people with epilepsy can have seizures even while taking their usual seizure medicine. It can worsen glaucoma or difficulty passing urine, and it needs caution with heart disease because it can speed the heart and lower blood pressure. Its anti-nausea effect can hide vomiting that would otherwise signal an overdose of another drug or a bowel blockage. People with a history of low white blood cell counts need blood tests during the first months, and anyone found to have low counts should report a fever or other sign of infection promptly. Babies exposed to antipsychotics in the last three months of pregnancy can have movement problems or withdrawal symptoms after birth, such as agitation, tremor, unusual muscle tone, sleepiness, breathing difficulty or trouble feeding; some need intensive care. Safe use in pregnancy has not been established, so the benefits of treatment are weighed against the possible risks to parent and baby. Anyone pregnant or planning pregnancy should talk with the prescriber before making changes. Breastfeeding is best avoided while taking loxapine when possible.
With oral loxapine, drowsiness and any movement side effects tend to show up early, while the dose is being built up over the first week or so. How fully symptoms improve varies from person to person. Because loxapine performed about as well as other antipsychotics in trials, a poor response or side effects that are hard to live with are reasons to discuss alternatives, not to give up on treatment. Loxapine is often continued as ongoing maintenance treatment once symptoms settle. The prescriber looks for the lowest dose that keeps symptoms controlled and periodically reassesses whether treatment is still needed, partly because the risk of tardive dyskinesia rises with longer use. Follow-up visits are a chance to check for new movements, sleepiness, dizziness and other effects, and to agree on any dose changes together. Adasuve is a single treatment for an episode of acute agitation, not ongoing therapy. Longer-term care continues with the person's regular treatment plan.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Loxapine, what you've noticed, or ask the community a question.